Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1795 of 5804
-
New stent graft approach aims to treat High-Risk aortic aneurysm patients
Disease control Recruiting nowThe purpose of this study is to evaluate safety and effectiveness of endovascular treatment of juxtarenal, pararenal and thoracoabdominal aortic aneurysms (with or without iliac artery involvement) using physician-modified stent grafts with a combination of fenestrations and/or b…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Morning or afternoon? new study tests best time for immunotherapy
Knowledge-focused Recruiting nowThis study aims to determine whether morning versus afternoon treatment impacts efficacy of (standard of care) immunotherapy in a broad patient population. Patients with any type of advanced/metastatic malignancy are eligible to enroll in this study, as long as first-line anti-PD…
Phase: PHASE2 • Sponsor: Liza Villaruz, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Custom-Made vaccine takes on aggressive breast cancer
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of a personalized vaccine (tumor membrane vesicle or TMV vaccine) by itself and in combination with checkpoint inhibitor (pembrolizumab or ipilimumab) in treating patients with triple negative breast cancer. This va…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 08:15 UTC
-
Trikafta's hidden effects: new study probes metabolism and microbiome in CF patients
Knowledge-focused Recruiting nowCystic Fibrosis (CF) is a genetic disease that affects multiple organs and systems. In recent years, the marketing of CFTR protein modulator drugs, such as the Elexacaftor-Tezacaftor-Ivacaftor (ETI) combination, has significantly improved patients' quality of life and prognosis. …
Sponsor: Meyer Children's Hospital IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Could a sleep drug fix chronic insomnia? new trial aims to find out
Disease control Not yet recruitingThe incidence of refractory insomnia is rising annually, with traditional therapies offering limited efficacy. Anesthesia-Induced Sleep (AIS), involving anesthetic infusion like dexmedetomidine, is emerging. Its ability to mimic natural sleep architecture is unclear. Studies conf…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a vein wrap stop nerve pain after injury? new study aims to find out.
Disease control Not yet recruitingPeripheral nerve injuries are common after trauma and may cause pain, sensory loss, motor deficit, and long-term disability. Scar formation and perineural adhesion at the repair site interfere with axonal regeneration, impair gliding of the nerve within surrounding tissues, and a…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Drug showdown: which pill tames cortisol better?
Disease control Recruiting nowThis study will compare the efficacy and safety of the two 11β-hydroxylase inhibitors-metyrapone and osilodrostat-in patients with MACS. Primary outcome To compare the efficacy (biochemical and clinical) of the two 11β-hydroxylase inhibitors (CYP11B1), metyrapone and osilodrosta…
Phase: PHASE4 • Sponsor: Laikο General Hospital, Athens • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New needle biopsy could spare women unnecessary uterus surgery
Diagnosis Not yet recruitingUterine tumor-like masses represent a wide spectrum of gynecological conditions, ranging from benign lesions such as myomas and adenomyosis to malignant tumors like endometrial carcinoma and leiomyosarcoma, as well as other entities including gestational trophoblastic disease \[4…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Blood markers may reveal breast Cancer's next move
Knowledge-focused Recruiting nowThis prospective observational study aims to evaluate serum levels of PTEN, a tumor suppressor gene, and organ-specific microRNAs (miRNAs) associated with metastatic patterns in breast cancer. Serum samples will be analyzed using quantitative reverse transcription polymerase chai…
Sponsor: Atlas University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New device could help surgeons spot brain tumors instantly
Diagnosis Not yet recruitingThe primary objective of this single-center study is to demonstrate the performance of cCeLL, used in real time, compared to frozen section analysis. The investigational device is intended for use with indocyanine green (ICG) for fluorescence imaging as an aid in the visualizatio…
Phase: PHASE1 • Sponsor: VPIX Medical • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Infertile women face higher violence risk, new study aims to measure it
Knowledge-focused Not yet recruitingInfertility is a major health concern with a great psychosocial impact. It's defined as the inability to achieve pregnancy after 12 months or more of regular unprotected sexual intercourse\[1\] affecting about 12%-25% of couples in Egypt\[2, 3\]. People in Egypt prefer extended …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Could a simple trigger point shot replace joint injections for hip pain?
Symptom relief Recruiting nowChronic musculoskeletal pain (CMP) is a common disease in China, with a high incidence among the elderly, and has a significant impact on patients' quality of life. Hip osteoarthritis is a common type of CMP. Currently, both domestic and international studies have confirmed that …
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New Under-the-Tongue pill aims to help men last longer
Symptom relief Recruiting nowThis is a Phase 2a, double-blind, placebo-controlled, crossover study evaluating the efficacy, safety, and patient-reported outcomes of KH-001 in men with lifelong premature ejaculation (LPE). Approximately 40 participants will receive KH-001 or placebo in two 4-week treatment pe…
Phase: PHASE2 • Sponsor: Kadence Bio • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can light detect skin cancer without a biopsy?
Diagnosis Recruiting nowSkin carcinomas are the most commonly diagnosed cancers in fair-skinned populations, for example in France, Western Europe, and North America in particular. The OpticSkin project will build and make available to the general public and the scientific and medical community a histol…
Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
AI takes on heart valve diagnosis: could it beat the experts?
Diagnosis Recruiting nowThis research project aims to develop and validate a tool that uses artificial intelligence (AI) to automatically detect and quantify aortic regurgitation (AR). The clinical efficacy of this tool will be established by comparing it to manual diagnostic methods in a multicenter ra…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
New study tests which drug combo best protects kidneys in hypertensive patients
Disease control Recruiting nowA study Comparing the Clinical Benefit of Finerenone Versus a Fixed-Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients with Hypertension and Chronic Kidney Disease.
Phase: PHASE3 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could vitamin d levels predict wheezing after bronchiolitis?
Knowledge-focused OngoingA prospective study will be conducted involving children under 2 years of age hospitalized for bronchiolitis during the period 2025-2026. Serum levels of 25-OH vitamin D (by chemiluminescence assay), VDR gene polymorphisms (through molecular techniques), and mitochondrial mass of…
Sponsor: National and Kapodistrian University of Athens • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Simple blood test may spot Life-Threatening HELLP syndrome sooner
Diagnosis Not yet recruitingPrimary Aim: \_To investigate the diagnostic potential of soluble CD163 (sCD163)as a novel biomarker for the early detection of HELLP syndrome, assessing its sensitivity and specificity compared to current diagnostic markers. Secondary Aims: 1. To evaluate the correlation betw…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
New hope for dizziness: CGRP drugs target vestibular migraine in major study
Symptom relief Not yet recruitingVestibular migraine is a phenotype of migraine, characterized by more prominent vertigo symptoms compared to headache. Treatments for VM are mainly divided into two categories: acute treatment and preventive treatment. Acute treatment aims to reduce the severity and duration of a…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Spinal zap device could ease chemo nerve pain
Symptom relief Recruiting nowThe goal of this observational study is to learn about the effectiveness of closed-loop spinal cord stimulation (CL-SCS) therapy for treatment of painful chemotherapy induced peripheral neuropathy. The closed-loop SCS (CL-SCS) system stimulates the nerves in the spinal cord, mea…
Sponsor: Rijnstate Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC